क्लिनिकल डर्मेटोलॉजी रिसर्च जर्नल

Fatal Dermatological Squeal Following Depot Medroxyprogesterone Acetate (DMPA) Administration: A Catastrophic Hypersensitivity Case Report

Aisha Siddiqui*1, Farina Fatima Siddiqui1 , Muhmmad Hamza Gul2 , Yugam Rajeshkumar Oza3 and Miruthu Varshini Jayaprakash4

The use of depot progesterone as a contraceptive every three months by a considerable number of women has raised concerns regarding the potential for hormones and chemicals to trigger fatal immune responses resulting in skin reactions. The focus of our case report is a 25-year-old woman who suffered a fatal dermatological condition after using this contraceptive. It is noteworthy that this specific condition has not been documented in medical literature before.

अस्वीकृति: इस सारांश का अनुवाद कृत्रिम बुद्धिमत्ता उपकरणों का उपयोग करके किया गया है और इसे अभी तक समीक्षा या सत्यापित नहीं किया गया है।